BMI1 and lip and oral cavity carcinoma: They also demonstrated downregulation of stemness markers, such as sox2, oct4, nanog, and bmi1, in the group treated with EVs loaded with miR-155 inhibitor, suggesting a possible correlation between stemness phenotype and resistance to DDP in oral cancer.